NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 316 filers reported holding NEOGENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $148,409 | -11.8% | 10,700 | 0.0% | 0.02% | -11.8% |
| Q1 2024 | $168,204 | -2.8% | 10,700 | 0.0% | 0.02% | -10.5% |
| Q4 2023 | $173,126 | +31.5% | 10,700 | 0.0% | 0.02% | +18.8% |
| Q3 2023 | $131,610 | -23.5% | 10,700 | 0.0% | 0.02% | -20.0% |
| Q2 2023 | $171,949 | -7.7% | 10,700 | 0.0% | 0.02% | -13.0% |
| Q1 2023 | $186,287 | +88.4% | 10,700 | 0.0% | 0.02% | +76.9% |
| Q4 2022 | $98,868 | +7.5% | 10,700 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $92,000 | +5.7% | 10,700 | 0.0% | 0.01% | +18.2% |
| Q2 2022 | $87,000 | -33.1% | 10,700 | 0.0% | 0.01% | -26.7% |
| Q1 2022 | $130,000 | -64.4% | 10,700 | 0.0% | 0.02% | -64.3% |
| Q4 2021 | $365,000 | -29.3% | 10,700 | 0.0% | 0.04% | -38.2% |
| Q3 2021 | $516,000 | +6.8% | 10,700 | 0.0% | 0.07% | +1.5% |
| Q2 2021 | $483,000 | -6.4% | 10,700 | 0.0% | 0.07% | -14.1% |
| Q1 2021 | $516,000 | +91.8% | 10,700 | +114.0% | 0.08% | +73.3% |
| Q4 2020 | $269,000 | – | 5,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 2,683,090 | $11,188,000 | 6.34% |
| GROW Partners, LLC | 1,140,300 | $4,755,000 | 4.35% |
| KOPP INVESTMENT ADVISORS LLC | 1,592,832 | $6,642,000 | 3.19% |
| PERKINS CAPITAL MANAGEMENT INC | 816,680 | $3,406,000 | 2.92% |
| 1492 Capital Management LLC | 786,495 | $3,280,000 | 2.05% |
| Curi RMB Capital, LLC | 4,177,053 | $17,418,000 | 1.06% |
| BARD ASSOCIATES INC | 491,100 | $2,048,000 | 0.96% |
| FALCON POINT CAPITAL, LLC | 162,475 | $678,000 | 0.62% |
| THB ASSET MANAGEMENT | 2,214,203 | $9,233,000 | 0.61% |
| NORTHPOINTE CAPITAL LLC | 1,033,821 | $4,311,000 | 0.52% |